Jörg Westermann
- Hematology top 5%
- Acute Myeloid Leukemia Research 25
- Chronic Myeloid Leukemia Treatments 13
- Immunology top 5%
- Immunotherapy and Immune Responses 22
- T-cell and B-cell Immunology 13
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 8
- Oncology top 5%
- CAR-T cell therapy research 17
-
- Renal cell carcinoma treatment 9
-
- Monoclonal and Polyclonal Antibodies Research 9
- Co-authors
- Bernd DörkenAntonio PezzuttoAnne FlörckenMartin LippUta E. HöpkenThomas BurmeisterNina Rosa NeuendorffJoachim Kopp
- Cited by
- HematologyImmunologyGenetics
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Jörg Westermann
79 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 78
- Hematology 340
- Immunology 611
- Genetics 193
- Oncology 476
- Pathology and Forensic Medicine 103
Countries citing papers authored by Jörg Westermann
This map shows the geographic impact of Jörg Westermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Westermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Westermann more than expected).
Fields of papers citing papers by Jörg Westermann
This network shows the impact of papers produced by Jörg Westermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Westermann. The network helps show where Jörg Westermann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jörg Westermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2021 | 16 | |
| 5 | 2018 | 19 | |
| 6 | 2017 | 2 | |
| 7 | 2016 | 31 | |
| 8 | 2016 | 18 | |
| 9 | 2015 | 24 | |
| 10 | 2014 | 56 | |
| 11 | 2014 | 8 | |
| 12 | 2013 | 5 | |
| 13 | 2012 | 26 | |
| 14 | 2011 | 28 | |
| 15 | 2011 | 15 | |
| 16 | 2008 | 1 | |
| 17 | 2007 | 30 | |
| 18 | 2005 | 6 | |
| 19 | 2005 | 6 | |
| 20 | 1998 | 0 |
About Jörg Westermann
Jörg Westermann is a scholar working on Hematology, Genetics and Immunology, having authored 85 papers that have together received 1.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (25 papers), Immunotherapy and Immune Responses (22 papers), CAR-T cell therapy research (17 papers), Chronic Myeloid Leukemia Treatments (13 papers), T-cell and B-cell Immunology (13 papers), Renal cell carcinoma treatment (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). The work is most often cited by research in Hematology (340 citations), Immunology (611 citations) and Genetics (193 citations). Jörg Westermann has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Bernd Dörken, Antonio Pezzutto, Anne Flörcken, Martin Lipp, Uta E. Höpken, Thomas Burmeister, Nina Rosa Neuendorff, Joachim Kopp, Antje van Lessen and Lars Bullinger. Their work appears in journals such as Blood, Cancer Gene Therapy, HemaSphere, British Journal of Haematology and Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.